ALLR
Allarity Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.21
+4.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.44x
- Price / sales
- 55.80x
- Price / cash flow
- -1.40x
Enterprise value
- Enterprise value
- $24.6M
- EV / sales
- 71.18x
- EV / EBITDA
- -2.22x
- EV / EBIT
- -2.27x
- Market cap
- $19.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026